Siddhartha Bhatt serves as a Senior Principal Scientist in Drug Safety R&D at Pfizer, where he leverages over a decade of experience in nonclinical safety to drive innovative drug development initiatives. His expertise in safety pharmacology positions him as a key contributor to multi-disciplinary project...
Siddhartha Bhatt serves as a Senior Principal Scientist in Drug Safety R&D at Pfizer, where he leverages over a decade of experience in nonclinical safety to drive innovative drug development initiatives. His expertise in safety pharmacology positions him as a key contributor to multi-disciplinary project teams, where he formulates and executes comprehensive derisking strategies across a diverse portfolio that includes vaccines, gene therapies, biologics, and treatments for rare diseases. Siddhartha's role as the safety pharmacology point of contact (POC) allows him to navigate complex regulatory landscapes, particularly in addressing cardiovascular safety concerns, ensuring that projects meet stringent regulatory standards while advancing through preclinical and clinical stages.
His track record as a portfolio representative and project toxicologist showcases his ability to lead matrixed cross-functional teams effectively, managing cross-discipline issues and ensuring timely deliverables across multiple active projects. Siddhartha's proficiency in Good Laboratory Practice (GLP) and non-GLP study design, coupled with his hands-on experience in animal models and rodent surgery, enhances his capability to oversee preclinical studies that inform critical safety assessments. With a strong foundation in molecular pharmacology and advanced techniques such as PCR, he is adept at integrating scientific insights into actionable strategies that mitigate risks and optimize drug safety profiles. Siddhartha's commitment to excellence and innovation in drug safety not only contributes to Pfizer's mission of delivering life-saving therapies but also positions him as a thought leader in the evolving landscape of pharmaceutical research and development.
